NVS logo

Novartis AG (NVS) Total Debt

Annual Total Debt

$26.35 B
-$1.56 B-5.59%

31 December 2023

NVS Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$32.16 B
+$3.17 B+10.94%

30 September 2024

NVS Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVS Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.6%+27.7%
3 y3 years-30.4%-6.3%
5 y5 years-17.9%+6.8%

NVS Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-30.4%at low-6.3%+27.7%
5 y5 years-30.4%at low-15.8%+27.7%
alltimeall time-30.4%+601.5%-15.8%

Novartis AG Total Debt History

DateAnnualQuarterly
Sept 2024
-
$32.16 B(+10.9%)
June 2024
-
$28.99 B(+6.2%)
Mar 2024
-
$27.28 B(+3.6%)
Dec 2023
$26.35 B(-5.6%)
$26.35 B(+4.6%)
Sept 2023
-
$25.19 B(-11.1%)
June 2023
-
$28.34 B(-3.0%)
Mar 2023
-
$29.20 B(+4.6%)
Dec 2022
$27.91 B(-10.0%)
$27.91 B(-2.2%)
Sept 2022
-
$28.54 B(-8.2%)
June 2022
-
$31.09 B(-0.8%)
Mar 2022
-
$31.34 B(+1.0%)
Dec 2021
$31.02 B(-18.0%)
$31.02 B(-9.6%)
Sept 2021
-
$34.33 B(-4.2%)
June 2021
-
$35.84 B(-5.3%)
Mar 2021
-
$37.84 B(-0.0%)
Dec 2020
$37.85 B(+29.9%)
$37.85 B(-0.8%)
Sept 2020
-
$38.17 B(+9.7%)
June 2020
-
$34.79 B(-5.2%)
Mar 2020
-
$36.70 B(+25.9%)
Dec 2019
$29.15 B(-9.2%)
$29.15 B(-3.2%)
Sept 2019
-
$30.12 B(-0.5%)
June 2019
-
$30.27 B(-1.1%)
Mar 2019
-
$30.59 B(-4.7%)
Dec 2018
$32.09 B(+12.9%)
$32.09 B(+1.0%)
Sept 2018
-
$31.78 B(-1.8%)
June 2018
-
$32.36 B(-5.1%)
Mar 2018
-
$34.11 B(+20.0%)
Dec 2017
$28.43 B(+20.0%)
$28.43 B(-5.8%)
Sept 2017
-
$30.16 B(-1.3%)
June 2017
-
$30.56 B(-2.2%)
Mar 2017
-
$31.26 B(+32.0%)
Dec 2016
$23.69 B(+8.2%)
$23.69 B(-10.8%)
Sept 2016
-
$26.57 B(+0.8%)
June 2016
-
$26.37 B(-6.1%)
Mar 2016
-
$28.09 B(+28.3%)
Dec 2015
$21.90 B(+7.6%)
$21.90 B(-3.5%)
Sept 2015
-
$22.70 B(-2.5%)
June 2015
-
$23.27 B(-7.3%)
Mar 2015
-
$25.11 B(+23.4%)
Dec 2014
$20.36 B(+13.6%)
$20.36 B(+3.8%)
Sept 2014
-
$19.61 B(-4.0%)
June 2014
-
$20.43 B(-3.7%)
Mar 2014
-
$21.21 B(+18.4%)
Dec 2013
$17.91 B(-9.2%)
$17.91 B(-4.6%)
Sept 2013
-
$18.77 B(-0.5%)
June 2013
-
$18.87 B(-9.9%)
Mar 2013
-
$20.94 B(+6.2%)
Dec 2012
$19.73 B
$19.73 B(-5.3%)
Sept 2012
-
$20.84 B(-7.9%)
June 2012
-
$22.63 B(-8.0%)
DateAnnualQuarterly
Mar 2012
-
$24.59 B(+21.6%)
Dec 2011
$20.23 B(-11.8%)
$20.23 B(-15.3%)
Sept 2011
-
$23.89 B(-13.1%)
June 2011
-
$27.50 B(-11.6%)
Mar 2011
-
$31.11 B(+35.6%)
Dec 2010
$22.94 B(+65.0%)
$22.94 B(-14.9%)
Sept 2010
-
$26.96 B(+44.6%)
June 2010
-
$18.64 B(+4.0%)
Mar 2010
-
$17.93 B(+28.9%)
Dec 2009
$13.91 B(+97.7%)
$13.91 B(-3.2%)
Sept 2009
-
$14.37 B(+3.6%)
June 2009
-
$13.87 B(+21.1%)
Mar 2009
-
$11.45 B(+62.8%)
Dec 2008
$7.04 B(+25.8%)
$7.04 B(-34.9%)
Sept 2008
-
$10.80 B(+0.7%)
June 2008
-
$10.73 B(+65.6%)
Mar 2008
-
$6.48 B(+15.8%)
Dec 2007
$5.59 B(-22.5%)
$5.59 B(-22.8%)
Sept 2007
-
$7.24 B(-2.8%)
June 2007
-
$7.45 B(+1.4%)
Mar 2007
-
$7.35 B(+1.9%)
Dec 2006
$7.22 B(-12.1%)
$7.22 B(-21.7%)
Sept 2006
-
$9.22 B(-2.2%)
June 2006
-
$9.43 B(+16.5%)
Mar 2006
-
$8.09 B(-1.4%)
Dec 2005
$8.21 B(+25.2%)
$8.21 B(+18.9%)
Sept 2005
-
$6.90 B(-10.3%)
June 2005
-
$7.69 B(+27.2%)
Mar 2005
-
$6.05 B(-7.8%)
Dec 2004
$6.56 B(+19.9%)
$6.56 B(+18.6%)
Sept 2004
-
$5.53 B(-7.6%)
June 2004
-
$5.99 B(-8.5%)
Mar 2004
-
$6.54 B(+19.6%)
Dec 2003
$5.47 B(+4.4%)
$5.47 B(-2.7%)
Sept 2003
-
$5.62 B(-19.3%)
June 2003
-
$6.97 B(+18.6%)
Mar 2003
-
$5.88 B(+12.2%)
Dec 2002
$5.24 B(+14.7%)
$5.24 B(+6.6%)
Sept 2002
-
$4.92 B(-2.7%)
June 2002
-
$5.05 B(>+9900.0%)
Mar 2002
-
$0.00(-100.0%)
Dec 2001
$4.57 B(+21.6%)
$4.57 B(>+9900.0%)
Sept 2001
-
$0.00(-100.0%)
June 2001
-
$4.33 B(>+9900.0%)
Mar 2001
-
$0.00(-100.0%)
Dec 2000
$3.76 B(-39.7%)
$3.76 B(>+9900.0%)
Sept 2000
-
$0.00(-100.0%)
June 2000
-
$5.09 B(>+9900.0%)
Mar 2000
-
$0.00
Dec 1999
$6.23 B(-3.8%)
-
Dec 1998
$6.48 B
-

FAQ

  • What is Novartis AG annual total debt?
  • What is the all time high annual total debt for Novartis AG?
  • What is Novartis AG annual total debt year-on-year change?
  • What is Novartis AG quarterly total debt?
  • What is the all time high quarterly total debt for Novartis AG?
  • What is Novartis AG quarterly total debt year-on-year change?

What is Novartis AG annual total debt?

The current annual total debt of NVS is $26.35 B

What is the all time high annual total debt for Novartis AG?

Novartis AG all-time high annual total debt is $37.85 B

What is Novartis AG annual total debt year-on-year change?

Over the past year, NVS annual total debt has changed by -$1.56 B (-5.59%)

What is Novartis AG quarterly total debt?

The current quarterly total debt of NVS is $32.16 B

What is the all time high quarterly total debt for Novartis AG?

Novartis AG all-time high quarterly total debt is $38.17 B

What is Novartis AG quarterly total debt year-on-year change?

Over the past year, NVS quarterly total debt has changed by +$6.97 B (+27.67%)